Molecular biology of the gene 
            Biologists in the 20th century have 
              not only discovered the rules of genetics, but also the link between 
              genes and traits. The discovery of the structure of the DNA double 
              helix in 1953 has provided an explanation for both inheritance, 
              the faithful copying of genetic information during reproduction, 
              and the genetic code, the rules of how genetic information is read 
              and used to make proteins, the work horses of cells. Francis Crick, 
              the codiscoverer of the DNA structure, was also instrumental in 
              cracking the code. He proposed the central dogma of molecular biology 
              that says that genetic information flows from DNA via RNA to proteins. 
              Armed with this concept, molecular biologists soon found the codon 
              nature of the genetic code. A codon is a three letter DNA instruction 
              to use one particular amino acid in a protein. A string of codons 
              in a gene (nucleotide sequence) thus results in a string of amino 
              acids in a protein (amino acid sequence). This linear correspondence 
              of the molecule structure of a nucleic acid polymer to make a amino 
              acid polymer is universal. That means the same code is used in all 
              known organisms. In a few cases, the exact assignment of which codon 
              sequence is used for which amino acid differs. Differences are found 
              in organellar DNA (mitochondrion and chloroplasts) and DNA of some 
              microorganisms. The latter reflects on the enormous genetic diversity 
              of microorganisms, which is much broader than diversity among plants 
              and animals.  
            The central dogma of molecular biology 
              had soon to be modified when it was discovered that some viruses 
              contain RNA instead of DNA in their genome, and that they are able 
              to make a DNA copy after successfully infecting a host cell. They 
              use a protein called reverse transcriptase, an enzyme that revolutionized 
              molecular biology because it allows to make genes from RNA. This 
              particular process is now used to study gene expression patterns 
              in organisms and get an understanding of how organisms use their 
              genes to carry out their metabolic and physiological functions. 
              It also demonstrated the central role of RNA in modern organisms. 
              Together with proteins, they control how and when genes are being 
              used. Today, the central dogma means that genetic information flows 
              from nucleic acid to nucleic acid, and from nucleic acid to protein, 
              but never from protein to nucleic acid. While proteins have control 
              over the copying mechanism of nucleic acids, proteins cannot make 
              copies of themselves or independent of the genetic blueprint. 
            Other enzymes were also central to 
              advancement of genetic engineering. Restriction enzymes that recognize 
              short, but highly specific sequences allow the cutting of DNA into 
              smaller fragments, which in turn can be spliced together in any 
              combination with the help of ligases. Since the genetic code and 
              structure of DNA is universal, this cut and past technique allows 
              the recombination of DNA from different organisms, as different 
              as bacteria and humans. Recombinant DNA technology has allowed construction 
              of microorganisms, plants, and farm animals with particular novel 
              traits. Such genetically modified organisms provide better growth 
              conditions, longer shelf-life of grocery items, but also the development 
              of novel medicine. Genetic engineering has been particularly useful 
              for drug development and drug production. One of the first medical 
              applications of recombinant DNA technology was the production of 
              the human insulin (a protein) in bacterial cell culture. Here the 
              human gene with the instructions for the amino acid sequence of 
              insulin has been spliced into a bacterial DNA (plasmid). The bacterial 
              cells can be easily grown in large numbers and triggered to synthesize 
              and release the insulin protein for isolation and purification.               
            
            Back 
              to table of content               
             
            H 
              o m e  
               Copyright © 1999-2011 
              Lukas K. Buehler               | 
          
             |